Citation Impact
Citing Papers
Vascular transcellular signaling.
1993
In situ click chemistry generation of cyclooxygenase-2 inhibitors
2017 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Child abuse: Adolescent records vs. adult recall
1990 Standout
Sodiumcalcium exchange in sarcolemmal vesicles from tracheal smooth muscle
1987
Health benefits of physical activity: the evidence
2006 Standout
5 Selective Inhibitors of Cyclooxygenase-2 (COT-2)
1999
Free radicals, antioxidants, and human disease: curiosity, cause, or consequence?
1994 Standout
2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary
2010
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Prevention of Corticosteroid Osteoporosis -- A Comparison of Calcium, Calcitriol, and Calcitonin
1993
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1999 Standout
How many drug targets are there?
2006 Standout
Nonredox 5-Lipoxygenase Inhibitors Require Glutathione Peroxidase for Efficient Inhibition of 5-Lipoxygenase Activity
1998
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
2003
Tumor necrosis factor α stimulates leukotriene production in vivo
1988 StandoutNobel
Vitamin D Deficiency
2007 Standout
Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds
1994 StandoutNobel
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Leukotriene-D4 induced cell shrinkage in Ehrlich ascites tumor cells
1989
Osteoporosis: now and the future
2011 Standout
Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells
2003 Standout
The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs
1997
Methylated ?-cyclodextrins are able to improve the nasal absorption of salmon calcitonin
1995
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
2001 Standout
Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
1996 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
2006 Standout
Flavonoids: a review of probable mechanisms of action and potential applications
2001 Standout
Progress and problems in the exploration of therapeutic targets
2006
Modern Synthetic Methods for Copper‐Mediated C(aryl)O, C(aryl)N, and C(aryl)S Bond Formation
2003 Standout
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
1998 Standout
Screening for Osteoporosis
1990
Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report
1994 Standout
Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>
1998 Standout
Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives
1991
Pharmacology and signaling of prostaglandin receptors: Multiple roles in inflammation and immune modulation
2004
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Review of the biology of quercetin and related bioflavonoids
1995 Standout
Mammalian lipoxygenases: molecular structures and functions
1992
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
1995 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis
1990
Paget’s Disease of Bone: Reduction of Disease Activity With Oral Risedronate
1998
Strong inhibition of mammalian lipoxygenases by the antiinflammatory seleno-organic compound ebselen in the absence of glutathione
1994
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
1993 Standout
Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model
1999
Asymmetric Multicomponent Reactions (AMCRs): The New Frontier
2005 Standout
COX-2 inhibitors
1999 Standout
Peroxynitrite: biochemistry, pathophysiology and development of therapeutics
2007 Standout
A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study
2000
Peroxynitrite-Induced Nitrotyrosination of Proteins Is Blocked by Direct 5-Lipoxygenase Inhibitor Zileuton
2001
Synthesis of Heterocycles via Electrophilic Cyclization of Alkynes Containing Heteroatom
2011 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
Antioxidant properties of phenolic compounds
1997 Standout
Drug targets in inflammation and immunomodulation
1997
Cyclooxygenases: Structural, Cellular, and Molecular Biology
2000 Standout
Differential effects of prostaglandin derived from ω-6 and ω-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion
2003
Comprehensive Survey of Combinatorial Library Synthesis: 2002
2003
Cyclooxygenase‐independent actions of cyclooxygenase inhibitors
2001
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Dioxygen Activation at Mononuclear Nonheme Iron Active Sites: Enzymes, Models, and Intermediates
2004 Standout
Alendronate Prevents Postmenopausal Bone Loss in Women without Osteoporosis: A Double-Blind, Randomized, Controlled Trial
1998
Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors, using sensitive microsomal and platelet assays
1997
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Sulfur Dioxide Mediated One-Pot, Three- and Four-Component Syntheses of Polyfunctional Sulfonamides and Sulfonic Esters: Study of the Stereoselectivity of the Ene Reaction of Sulfur Dioxide
2004
Leukotrienes cause eosinophil emigration into conjunction tissue
1986
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Bone metabolism and disease in chronic kidney disease
2003
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
CD34-deficient mice have reduced eosinophil accumulation after allergen exposure and show a novel crossreactive 90-kD protein
1996 StandoutNobel
AUTONOMIC PHARMACOLOGY OF LEUKOTRIENES
1985
LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia
2006 Standout
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
1995 Standout
Works of D. Denis being referenced
Characterization of autocrine inducible prostaglandin H synthase-2 (PGHS-2) in human osteosarcoma cells
1997
1-YEAR CONTROLLED RANDOMISED TRIAL OF PREVENTION OF EARLY POSTMENOPAUSAL BONE LOSS BY INTRANASAL CALCITONIN
1987
Biological and clinical assessment of a new bisphosphonate, (chloro-4 phenyl)thiomethylene bisphosphonate, in the treatment of Paget's disease of bone
1988
Structure–Activity Relationship of Biaryl Acylsulfonamide Analogues on the Human EP3 Prostanoid Receptor
2002
L-649,923, Sodium (βS*, γR*)-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)-propylthio)-γ-hydroxy-β-methylbenzenebutanoate, a selective, orally active leukotriene receptor antagonist
1986
Stimulation of 5-lipoxygenase activity under conditions which promote lipid peroxidation
1989
Synthesis and biological activities of leukotriene F4 and leukotriene F4 sulfone
1982
Pharmacological study of the effects of leukotrienes C4, D4, E4 & F4 on guinea pig trachelis: Interaction with FPL-55712
1983
Characterization of the activity of purified recombinant human 5-lipoxygenase in the absence and presence of leukocyte factors.
1991
L-649,923, sodium (beta S*, gamma R*-4-(3-(4-acetyl-3-hydroxy-2-propylphenoxy)propylthio)-gamma-hydroxy -beta-methylbenzenebutanoate. A selective, orally active leukotriene D4 receptor antagonist.
1986
Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects.
1987
Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitonin
1994
Study of mechanisms mediating contraction to leukotriene C4, D4 and other bronchoconstrictors on guinea pig trachea
1984